Vaccines - Research and Data from KFF

Are There Enough COVID-19 Vaccines for America Without More Funding?

Mar 25, 2022

Issue Brief

This Data Note estimates how far the current U.S. supply of COVID-19 vaccines could stretch under different vaccination and booster scenarios. While estimated U.S. COVID-19 vaccine supply needs vary widely depending on assumptions and how many people choose to get vaccinated, this analysis indicates that under a plausible set of scenarios where 4th doses are recommended, the federal government is unlikely to have enough doses already purchased to cover the U.S. population.

Vaccinating the World: How Does the U.S. Stack Up Against Other Donors?

Mar 3, 2022

Issue Brief

This analysis looks at the amount of funding for vaccines and the number of vaccine doses that have been donated to the global COVID-19 vaccine effort and standardizes these donations based on the size of donor economies.

KFF COVID-19 Vaccine Monitor: February 2022

Mar 1, 2022

Poll Finding

Two years into the COVID-19 pandemic, the public is split on their readiness to return to normal, with many worried about the consequences of lifting restrictions and of not lifting them. At this point, the pandemic is not a top issue for voters in November's midterm elections . Most parents are not confident in the safety of the vaccine for kids under 5.

Large Shares of the Public Worry about the Consequences of Both Ending and Keeping COVID-19 Restrictions, with Partisans Largely Split on Which Direction is Most Concerning

Mar 1, 2022

News Release

As federal, state, and local authorities move to roll back COVID-19 restrictions, a new KFF COVID-19 Vaccine Monitor survey finds many people ready to get back to normal but a public also nervous about the potential consequences.

Analysis Finds The Share of Nursing Home Staff Who Have Been Vaccinated Against COVID-19 Varies Substantially by State

Feb 17, 2022

News Release

The share of nursing home staffers who have been fully vaccinated against COVID-19 varies considerably by state, from 70 percent in Ohio to 99 percent in Maine, Rhode Island, New York and Massachusetts, a new KFF analysis finds. The national average is 84 percent.

Diversity of Under-5 Age Group Varies Across States

Feb 10, 2022

Feature

Of the 19 million U.S. children under 5, half are children of color, making this group more diverse than the U.S. population overall. There is also significant variation across the country.

FAQs on Medicare Coverage and Costs Related to COVID-19 Testing and Treatment

Feb 3, 2022

Issue Brief

These FAQs provide the latest guidance on testing and treatment related to COVID-19 for Medicare beneficiaries, including questions related to out-of-pocket costs, the COVID-19 vaccine, telehealth, extended supplies of medication, skilled nursing facility stays, and issues for people in private Medicare Advantage plans.

Vaccine Monitor: 6 in 10 Parents of Teens and One-Third of Parents of 5-11 Year-Olds Say Their Child is Vaccinated for COVID-19, Both Up Since November

Feb 1, 2022

News Release

3 in 10 of Those with Children Under 5 Expect to Get Them a Shot Right Away Once Eligible 1 in 4 Parents Say Their Student Had to Quarantine in January Due to COVID-19 Infection or Exposure; Overall 4 in 10 Report Some Education Disruption Growing shares of parents say that their eligible children have…

KFF COVID-19 Vaccine Monitor: January 2022 Parents And Kids Update

Feb 1, 2022

Poll Finding

This Vaccine Monitor survey finds an increase in the share of parents reporting their child has received a COVID-19 vaccine, with 61% of parents of 12-17-year olds and 33% of 5-11-year-olds now saying their child has gotten at least one shot. Three in ten parents of children under the age of 5, a group that has not yet been approved to get a vaccine, say they’ll get their child vaccinated right away.

42% of Adults, and 70% of Those Likely Booster-Eligible, Now Say They’ve Gotten a COVID-19 Booster Shot; The Share Who Received At Least One Dose Inches Up to 77% in Omicron’s Wake

Jan 28, 2022

News Release

6 in 10 Who Tried to Purchase an At-Home Test and a Third Who Sought an In-Person Test Say It Was Difficult to Find, Though Most Were Eventually Able to Get a Test Black and Hispanic Adults are More Likely Than White Adults to Worry About Omicron’s Effects, Including Becoming Seriously Ill or Missing Work…

Topics

Policy Research

Polling

Health News

Data & Features

For Media

About

View the Latest: Vaccines

Filter